These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 467240)

  • 21. Vasodilator drugs in the treatment of hypertension.
    Kincaid-Smith P
    Med J Aust; 1985 Apr; 142(8):450-3. PubMed ID: 3884988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective treatment of refractory hypertension by combination of direct vasodilators.
    Gerlag PG
    Neth J Med; 1983; 26(9):271-3. PubMed ID: 6656978
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs in the management of hypertension. Part III.
    Page LT; Yager HM; Sidd JJ
    Am Heart J; 1976 Aug; 92(2):252-9. PubMed ID: 945939
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of systemic hypertension in children.
    Reisman L; Selden RV
    Pediatr Ann; 1982 Jul; 11(7):604-5, 607-10, 612-3. PubMed ID: 7050855
    [No Abstract]   [Full Text] [Related]  

  • 25. The pharmacologic basis of antihypertensive therapy: The role of vasodilator drugs.
    Chidsey CA; Gottlieb TB
    Prog Cardiovasc Dis; 1974; 17(2):99-113. PubMed ID: 4153137
    [No Abstract]   [Full Text] [Related]  

  • 26. Choice of antihypertensive drugs for the treatment of hypertension, including hypertensive emergencies.
    Vidt DG
    Cardiovasc Clin; 1974; 6(2):199-221. PubMed ID: 4155351
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacotherapy of arterial hypertension].
    Gessler U; Pilgrim R
    Fortschr Med; 1977 Aug; 95(31):1912-5. PubMed ID: 892686
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vasodilators, modern therapeutic approach in pulmonary arterial hypertension].
    Gherasim L; Bogdan M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(2):97-102. PubMed ID: 6127777
    [No Abstract]   [Full Text] [Related]  

  • 29. Current indications for vasodilator therapy for left ventricular failure.
    Franciosa JA
    Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926
    [No Abstract]   [Full Text] [Related]  

  • 30. Vasodilating drugs: contrasting haemodynamic effects.
    Tarazi RC; Dustan HP; Bravo EL; Niarchos AP
    Clin Sci Mol Med Suppl; 1976 Dec; 3():575s-578s. PubMed ID: 1071683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasodilator therapy in primary pulmonary hypertension.
    Elkayam U
    Chest; 1981 Mar; 79(3):253-4. PubMed ID: 7471853
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasodilator therapy of congestive heart failure.
    Cohn JN
    Adv Intern Med; 1980; 26():293-315. PubMed ID: 6784453
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of malignant hypertension.
    Grim CE
    Compr Ther; 1980 May; 6(5):43-8. PubMed ID: 7379487
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prazosin, a new peripheral vasodilator agent compared with hydralazine].
    Rasmussen K; Aerenlund Jensen H
    Ugeskr Laeger; 1976 Aug; 138(32):1940-3. PubMed ID: 951801
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacologic approach to the management of childhood hypertension.
    Pruitt AW
    Pediatr Clin North Am; 1981 Feb; 28(1):135-44. PubMed ID: 7208133
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasodilator treatment of primary pulmonary hypertension.
    Cotter L
    Adv Exp Med Biol; 1984; 164():359-68. PubMed ID: 6695579
    [No Abstract]   [Full Text] [Related]  

  • 37. The treatment of resistant hypertension.
    Kincaid-Smith PS
    Drugs; 1976; 11 SUPPL 1():78-86. PubMed ID: 6254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertensive crisis.
    Ram CV
    Cardiol Clin; 1984 May; 2(2):211-25. PubMed ID: 6399864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical use of new antihypertensives].
    Song YC
    Zhonghua Yi Xue Za Zhi; 1984 Aug; 64(8):503-7. PubMed ID: 6440700
    [No Abstract]   [Full Text] [Related]  

  • 40. Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans.
    Leenen FH; Smith DL; Farkas RM; Reeves RA; Marquez-Julio A
    Am J Med; 1987 May; 82(5):969-78. PubMed ID: 2953239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.